These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 15472813)

  • 1. Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Oh MD; Kim EC; Choe KW
    Clin Infect Dis; 2004 Sep; 39(6):812-8. PubMed ID: 15472813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enterobacter bacteremia: Clinical features, risk factors for multiresistance and mortality in a Chinese University Hospital.
    Ye Y; Li JB; Ye DQ; Jiang ZJ
    Infection; 2006 Oct; 34(5):252-7. PubMed ID: 17033748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and predictors of mortality in patients with Enterobacter aerogenes bacteremia.
    Chang EP; Chiang DH; Lin ML; Chen TL; Wang FD; Liu CY
    J Microbiol Immunol Infect; 2009 Aug; 42(4):329-35. PubMed ID: 19949757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of in-hospital mortality for bloodstream infections caused by Enterobacter species or Citrobacter freundii.
    Deal EN; Micek ST; Ritchie DJ; Reichley RM; Dunne WM; Kollef MH
    Pharmacotherapy; 2007 Feb; 27(2):191-9. PubMed ID: 17253909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and treatment outcomes of bloodstream infection caused by extended-spectrum cephalosporin-resistant Enterobacter species in adults with cancer.
    Huh K; Kang CI; Kim J; Cho SY; Ha YE; Joo EJ; Chung DR; Lee NY; Peck KR; Song JH
    Diagn Microbiol Infect Dis; 2014 Feb; 78(2):172-7. PubMed ID: 24321352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical epidemiology of ciprofloxacin resistance and its relationship to broad-spectrum cephalosporin resistance in bloodstream infections caused by Enterobacter species.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
    Infect Control Hosp Epidemiol; 2005 Jan; 26(1):88-92. PubMed ID: 15693414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae.
    Henshke-Bar-Meir R; Yinnon AM; Rudensky B; Attias D; Schlesinger Y; Raveh D
    Infection; 2006 Apr; 34(2):66-74. PubMed ID: 16703295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4574-81. PubMed ID: 15561828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteraemia.
    Ko WC; Lee HC; Chuang YC; Liu CC; Wu JJ
    J Infect; 2000 May; 40(3):267-73. PubMed ID: 10908022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of previous use of antibiotics on development of resistance to extended-spectrum cephalosporins in patients with enterobacter bacteremia.
    Lee SO; Kim YS; Kim BN; Kim MN; Woo JH; Ryu J
    Eur J Clin Microbiol Infect Dis; 2002 Aug; 21(8):577-81. PubMed ID: 12226687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteremia due to extended-spectrum beta-lactamase-producing Enterobacteriaceae other than Escherichia coli and Klebsiella.
    Huang SS; Lee MH; Leu HS
    J Microbiol Immunol Infect; 2006 Dec; 39(6):496-502. PubMed ID: 17164953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes.
    Freeman JT; McBride SJ; Nisbet MS; Gamble GD; Williamson DA; Taylor SL; Holland DJ
    Int J Infect Dis; 2012 May; 16(5):e371-4. PubMed ID: 22401750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment outcomes in patients with third-generation cephalosporin-resistant Enterobacter bacteremia.
    O'Neal CS; O'Neal HR; Daniels TL; Talbot TR
    Scand J Infect Dis; 2012 Oct; 44(10):726-32. PubMed ID: 22681412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.
    Tumbarello M; Sanguinetti M; Montuori E; Trecarichi EM; Posteraro B; Fiori B; Citton R; D'Inzeo T; Fadda G; Cauda R; Spanu T
    Antimicrob Agents Chemother; 2007 Jun; 51(6):1987-94. PubMed ID: 17387156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for mortality and impact of broad-spectrum cephalosporin resistance on outcome in bacteraemic intra-abdominal infections caused by Gram-negative bacilli.
    Kang CI; Chung DR; Ko KS; Peck KR; Song JH;
    Scand J Infect Dis; 2011 Mar; 43(3):202-8. PubMed ID: 21142623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and risk factors for attributable mortality in Enterobacter cloacae bacteremia.
    Lin YC; Chen TL; Ju HL; Chen HS; Wang FD; Yu KW; Liu CY
    J Microbiol Immunol Infect; 2006 Feb; 39(1):67-72. PubMed ID: 16440126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serratia marcescens bacteremia at a medical center in southern Taiwan: high prevalence of cefotaxime resistance.
    Shih HI; Lee HC; Lee NY; Chang CM; Wu CJ; Wang LR; Ko NY; Ko WC
    J Microbiol Immunol Infect; 2005 Oct; 38(5):350-7. PubMed ID: 16211144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of antibiotic-resistant Gram-negative bacilli infections on outcome in hospitalized patients.
    Raymond DP; Pelletier SJ; Crabtree TD; Evans HL; Pruett TL; Sawyer RG
    Crit Care Med; 2003 Apr; 31(4):1035-41. PubMed ID: 12682469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical relevance of Enterobacter infections.
    Shlaes DM
    Clin Ther; 1993; 15 Suppl A():21-8. PubMed ID: 8513457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.